SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-062306
Filing Date
2013-11-15
Accepted
2013-11-15 12:54:05
Documents
7
Period of Report
2013-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v360427_8k.htm 8-K 23668
2 EXHIBIT 1.1 v360427_ex1-1.htm EX-1.1 238277
3 EXHIBIT 5.1 v360427_ex5-1.htm EX-5.1 10246
4 EXHIBIT 99.1 v360427_ex99-1.htm EX-99.1 7423
5 EXHIBIT 99.2 v360427_ex99-2.htm EX-99.2 8225
6 GRAPHIC image_001.jpg GRAPHIC 6330
7 GRAPHIC image_002.jpg GRAPHIC 6330
  Complete submission text file 0001144204-13-062306.txt   306699
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 131223259
SIC: 2836 Biological Products, (No Diagnostic Substances)